PCM - Pharma Consulting & Management GmbH > In-/Out-Licensing > Ethical > Natural surfactant for prevention and treatment of RDS - available for licensing

Ethical pharmaceuticals

Natural surfactant for prevention and treatment of RDS

Active ingredient

Phospholipid fraction from bovine lungs.


Prevention of respiratory distress syndrome (RDS) in premature infants.

Treatment of infantile respiratory distress syndrome (RDS).

Pharmaceutical form and presentations

Lyophilized phospholipids in vials with 50 mg and 100 mg.

Syringe with solvent for reconstitution.


Intratracheal instillation.

Special feature

Storage at room temperature.

Produced in

European Union.

Available countries

On request.


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.